A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants
Clinical trial NCT06693765 · COMPLETED
Trial details
- NCT number
- NCT06693765
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2025-04-23
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.